Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells
To access this article, please choose from the options below
PII: S1368-8375(04)00024-7
doi:10.1016/j.oraloncology.2004.01.013
© 2004 Published by Elsevier Inc.
